Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Theoretical Biology|July 25, 2006
Monte Carlo sampling and principal component analysis of flux distributions yield topological and modular information on metabolic networksBerna Sariyar, Sinem Perk, Uğur Akman, et al.Cryobiology|July 19, 2015
Machine perfusion enhances hepatocyte isolation yields from ischemic liversMaria-Louisa Izamis, Sinem Perk, Candice Calhoun, et al.Journal of Medical Economics|January 31, 2017
Economic outcomes with the conversion of insulin delivery methods in hospitalsKari A Kelton, Sinem Perk, Scott Loveland, et al.BMC Research Notes|June 27, 2012
A fitness index for transplantation of machine-perfused cadaveric rat liversSinem Perk, Maria-Louisa Izamis, Herman Tolboom, et al.Archives of Microbiology|August 1, 2007
Preliminary phenotypic characterization of newly isolated halophilic microorganisms by footprinting: a rapid metabolome analysisBerna Sariyar-Akbulut, Aydan Salman-Dilgimen, Selim Ceylan, et al.Plos One|December 24, 2011
A metabolic index of ischemic injury for perfusion-recovery of cadaveric rat liversSinem Perk, Maria-Louisa Izamis, Herman Tolboom, et al.Nature Materials|August 18, 2014
Collective and individual migration following the epithelial-mesenchymal transitionIan Y Wong, Sarah Javaid, Elisabeth A Wong, et al.Pharmacotherapy|October 7, 2016
Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult PopulationNoll L Campbell, Anthony J Perkins, Pamela Bradt, et al.Journal of Medical Economics|June 22, 2016
Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectivesRonald C Wielage, Sinem Perk, Noll L Campbell, et al.Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive BladderSinem Perk, Ronald C Wielage, Noll L Campbell, et al.Pageof 2